Clinical Trial Update: SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma patients with partial response to transarterial chemoemboli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of Sao Paulo | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: ACTIVE_NOT_RECRUITING